Zoniporide
Alternative Names: CP 597396Latest Information Update: 05 Aug 2009
Price :
$50 *
At a glance
- Originator Pfizer
- Class Guanidines; Pyrazoles
- Mechanism of Action Sodium-hydrogen antiporter inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Cardiovascular disorders
Most Recent Events
- 06 Nov 2002 Phase-II clinical trials in Cardiovascular disorders in USA (unspecified route)